reports
Funding Circle Plc: POS-Transaction in Own Shares
Funding Circle Plc (FCH) Funding Circle Plc: POS-Transaction in Own Shares 18-Apr-2024 / 17:07 GMT/BST LEI: 2138003EK6UAINBBUS19 18 April 2024 Funding Circle Holdings plcTransaction in own shares Funding Circle Holdings plc (the "Company") announces that it has purchased for cancellation the following number of its ordinary shares of £0.001 each on the London Stock Exchange from Numis Securities Limited (“Deutsche Numis”) as part of its buy-back announced on 7 March 2024: Date of purchase: 18 April 2024 Number of ordinary shares purchased: ...
Ölgerðin Egill Skallagrímsson hf.: Ársreikningur fyrir 1. mars 2023 ti...
Ölgerðin Egill Skallagrímsson hf.: Ársreikningur fyrir 1. mars 2023 til 29. febrúar 2024 Ársreikningur samstæðu Ölgerðarinnar Egils Skallagrímssonar hf. fyrir tímabilið 1. mars 2023 – 29. febrúar 2024 var samþykktur af stjórn og forstjóra á stjórnarfundi 18. apríl 2024. Helstu niðurstöður fjárhagsársins sem og fjórða ársfjórðungs 2023 (Q4 2023) eru: EBITDA fjárhagsársins nam 5.504 millj. kr. samanborið við 4.560 millj. kr. á fyrra ári, sem jafngildir 21% hækkun milli ára (Q4 hækkaði EBITDA um 15,7% á milli ára).Vörusala samstæðu Ölgerðarinnar var 18% meiri en árið áður (Q4 velta ...
Life & Banc Split Corp. Announces Successful Overnight Offering
Life & Banc Split Corp. Announces Successful Overnight Offering Not for distribution to U.S. newswire services or for dissemination in the United States. TORONTO, April 18, 2024 (GLOBE NEWSWIRE) -- (TSX: LBS, LBS.PR.A) Life & Banc Split Corp. (the “Fund”) is pleased to announce a successful overnight treasury offering of class A shares and preferred shares (the “Class A Shares” and “Preferred Shares”, respectively). Gross proceeds of the offering are expected to be approximately $27.9 million. The offering is expected to close on or about April 25, 2024 and is subject to certain closing...
Fuller, Smith & Turner PLC: Transaction in own shares
Fuller, Smith & Turner PLC (FSTA) Fuller, Smith & Turner PLC: Transaction in own shares 18-Apr-2024 / 16:59 GMT/BST Fuller, Smith & Turner P.L.C. (“the Company” or “Fuller’s”) Transaction in own shares The Company announces that it has purchased the following number of its ‘A' ordinary shares of 40p each on the London Stock Exchange through Numis Securities Limited as part of its share buyback programme announced on 22 March 2024 (the “Programme”). Date of Purchase 18/04/2024 Number of ‘A’ ordinary shares of 40p each ...
Smart for Life Announces 1-for-7 Reverse Stock Split
Smart for Life Announces 1-for-7 Reverse Stock Split MIAMI, April 18, 2024 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a leader in the Health & Wellness sector marketing and manufacturing nutritional foods and supplements worldwide, announced that it will effect a 1-for-7 reverse stock split (“reverse split”) of its common stock, par value $0.0001 per share (“common stock”) and its authorized stock, that will become effective on April 22, 2024. Smart for Life’s common stock will continue to trade on The Nasdaq Capital Market (“Nasdaq”) unde...
Amplitude Surgical - Chiffre d’affaires consolidé 9 mois de l’exercice...
VALENCE, France--(BUSINESS WIRE)-- Regulatory News: Amplitude Surgical (ISIN : FR0012789667, Mnémo : AMPLI, éligible PEA-PME), leader français sur le marché des technologies chirurgicales destinées à l’orthopédie pour les membres inférieurs, annonce son chiffre d’affaires consolidé pour le troisième trimestre de l’exercice 2023-24. Olivier Jallabert, Directeur Général d’Amplitude Surgical, déclare : « Au cours des 9 premiers mois de l’exercice 2023-24, Amplitude Surgical a poursuivi sa trajectoire de croissance et affiche une progression de son chiffre d’affaires de +6,1% à taux constants ...
First quarter 2024 sales
First quarter 2024 sales A very good start to the year High single digit rhythm maintained Sales: 11.24 billion euros, +9.4% like-for-like1, +8.3% reported.First quarter sales included a positive 130 million euro phasing impact ahead of the implementation of new IT systems in North America. Adjusted like-for-like growth amounted to a strong +8.1%.Continued outperformance in a global beauty market that remained dynamic.All Divisions grew with stellar performances from the Consumer Products and Dermatological Beauty DivisionsParticularly remarkable growth...
Chiffre d’affaires du 1er trimestre 2024
Chiffre d’affaires du 1er trimestre 2024 TRÈS BON DÉBUT D’ANNÉEMAINTIEN D’UN RYTHME DE CROISSANCE SOUTENU Chiffre d’affaires : 11,24 milliards d’euros, + 9,4 % en comparable1, + 8,3 % en publié.Les ventes du 1er trimestre incluent un impact favorable de phasage en Amérique du Nord de 130 millions d’euros lié à la mise en place de nouveaux systèmes informatiques. La croissance ajustée à données comparables est forte à + 8,1 %.Surperformance continue dans un marché mondial de la beauté qui reste dynamique.Croissance dans toutes les Divisions, avec des performances spectaculaires d...
IntegraGen : Résultats annuels 2023 – Excédent brut d’exploitation pos...
EVRY, France--(BUSINESS WIRE)-- Regulatory News: IntegraGen (FR0010908723 – ALINT – Eligible PEA PME), une société du groupe OncoDNA spécialisée dans la génomique du cancer et des maladies génétiques rares, qui réalise des analyses génomiques interprétables pour des laboratoires académiques et privés, annonce aujourd'hui ses résultats annuels audités pour l’exercice 2023, les comptes ayant été arrêtés par le Conseil d'administration du 5 avril 2024. Bernard Courtieu, Directeur Général d’IntegraGen, déclare : « Les résultats 2023 démontrent que malgré l’arrêt ou la forte diminution des acti...
Aelis Farma annonce la dernière visite du dernier patient (Last Patien...
BORDEAUX, France--(BUSINESS WIRE)-- Regulatory News: Aelis Farma (ISIN : FR0014007ZB4 – Mnémonique : AELIS, éligible PEA-PME), société biopharmaceutique au stade clinique spécialisée dans le développement de traitements pour les maladies du cerveau, annonce le franchissement d’une nouvelle étape dans le développement clinique de AEF0117 avec la réalisation de la dernière visite médicale du dernier patient inclus dans l’étude de phase 2b ayant inclus 333 patients souffrant d’addiction au cannabis ou CUD (Cannabis Use Disorder). AEF0117 est le premier représentant d’une nouvelle classe de mé...
CI Financial Announces First Quarter Earnings Conference Call and Webc...
TORONTO--(BUSINESS WIRE)-- (“CI”) (TSX: CIX) will release its financial results for the first quarter of fiscal 2024 on Friday, May 10, 2024. CI will hold a conference call with analysts that day at 9:00 a.m. EDT, led by Chief Executive Officer Kurt MacAlpine and Chief Financial Officer Amit Muni. A live webcast of the call and slide presentation can be accessed or through the section of CI’s website. Alternatively, investors may listen to the discussion through the following numbers (access code: 155730): Canada toll-free: 1-833-950-0062 United States toll-free: 1-833-470-1428 ...
Mortgage Rates Exceed 7 Percent for the First Time this Year
Mortgage Rates Exceed 7 Percent for the First Time this Year MCLEAN, Va., April 18, 2024 (GLOBE NEWSWIRE) -- (OTCQB: FMCC) today released the results of its (PMMS®), showing the 30-year fixed-rate mortgage (FRM) averaged 7.10 percent. “The 30-year fixed-rate mortgage surpassed 7 percent for the first time this year, jumping from 6.88 percent to 7.10 percent this week,” said Sam Khater, Freddie Mac’s Chief Economist. “As rates trend higher, potential homebuyers are deciding whether to buy before rates rise even more or hold off in hopes of decreases later in the year. Last week, purchas...
EssilorLuxottica: Q1 2024 Revenue - Solid revenue trend in the first q...
EssilorLuxottica: Q1 2024 Revenue - Solid revenue trend in the first quarter Q1 2024 Revenue Solid revenue trend in the first quarter Q1 revenue up 5.5% at constant exchange rates1All the regions growing, in both PS and DTC channelsAlso North America positive, on a softer paceStrong growth in EMEA, across all channels and categoriesProduct innovation and new brands as a key growth factor, driving price/mix upVarilux, Stellest and Ray-Ban Meta continuing to accelerate Charenton-le-Pont, France (April 18, 2024 - 6:00 pm) – EssilorLuxottica announced today that consolidated revenue for the ...
EssilorLuxottica: Fatturato del primo trimestre 2024 - Solida traietto...
EssilorLuxottica: Fatturato del primo trimestre 2024 - Solida traiettoria di crescita del fatturato nel primo trimestre Fatturato del primo trimestre 2024 Solida traiettoria di crescita del fatturato nel primo trimestre Fatturato del primo trimestre in aumento del 5,5% a cambi costanti1Tutte le aree geografiche in crescita, in entrambi i segmenti Professional Solutions e Direct to ConsumerIl Nord America positivo con un ritmo meno sostenutoEMEA in forte crescita in tutti i canali e le categorie Innovazione di prodotto e nuovi brand fattori chiave della crescita, portando a un migliorament...
Changement de gouvernance à la tête du Conseil de surveillance de NEOL...
Changement de gouvernance à la tête du Conseil de surveillance de NEOLIFE Changement de gouvernance à la tête du Conseil de surveillance de NEOLIFE NEOLIFE® (Euronext Growth : FR0011636083 – ALNLF), acteur majeur des éco-matériaux issus des technologies vertes et reconnu pour son innovation en solutions constructives durables, annonce un changement de gouvernance à la tête du Conseil de surveillance. Monsieur Patrick MARCHÉ Fondateur et Président du Conseil de surveillance a présenté sa démiss...
Annual general meeting 2024: all proposals of the board of directors a...
Bucher Industries AG / Key word(s): AGMEGM/Dividend Annual general meeting 2024: all proposals of the board of directors approved 18.04.2024 / 17:52 CET/CEST At today’s annual general meeting (AGM) of Bucher Industries AG, the shareholders agreed to all the proposals put forward by the board of directors. The dividend is CHF 13.50 per registered share. 187 shareholders with voting rights were present and a total of 75.92% of the votes were represented. At the annual general meeting, which was held today at the Mövenpick Hotel in Regensdorf, the Group reported that 2023 had been a...
Generalversammlung 2024: alle Anträge des Verwaltungsrats genehmigt
Bucher Industries AG / Schlagwort(e): Generalversammlung/Dividende Generalversammlung 2024: alle Anträge des Verwaltungsrats genehmigt 18.04.2024 / 17:52 CET/CEST Die Aktionärinnen und Aktionäre haben an der heutigen Generalversammlung (GV) der Bucher Industries AG sämtlichen Anträgen des Verwaltungsrats stattgegeben. Die Dividende beträgt CHF 13.50 pro Namenaktie. 187 Stimmberechtigte waren anwesend und insgesamt 75.92% der Stimmen vertreten. An der heutigen Generalversammlung im Mövenpick Hotel in Regensdorf berichtete der Konzern von einem sehr erfolgreichen Geschäftsjahr 2023...
UBM Development AG: 1 director
A director at UBM Development AG bought 5,000 shares at 19.720EUR and the significance rating of the trade was 60/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...
Egyptian For Tourism Resorts: 1 director
A director at Egyptian For Tourism Resorts bought 1,049,812 shares at 0.000EGP and the significance rating of the trade was 60/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last ...
Egyptians Housing Development & Reconstruction: 1 director
A director at Egyptians Housing Development & Reconstruction bought 101,046,380 shares at 0.000EGP and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's dir...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.